Cargando…
Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells
Despite considerable efficacy of arsenic trioxide (As(2)O(3)) in acute promyelocytic leukemia (APL) treatment, other non-APL leukemias, such as chronic myeloid leukemia (CML), are less sensitive to As(2)O(3) treatment. However, the underlying mechanism is not well understood. Here we show that relat...
Autores principales: | Song, Li-Li, Tu, Yao-Yao, Xia, Li, Wang, Wei-Wei, Wei, Wei, Ma, Chun-Min, Wen, Dong-Hua, Lei, Hu, Xu, Han-Zhang, Wu, Ying-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130628/ https://www.ncbi.nlm.nih.gov/pubmed/25115845 http://dx.doi.org/10.1371/journal.pone.0104985 |
Ejemplares similares
-
Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
por: Li, Nainong, et al.
Publicado: (2015) -
A Novel Resveratrol-Arsenic Trioxide Combination Treatment Synergistically Induces Apoptosis of Adriamycin-Selected Drug-Resistant Leukemia K562 Cells
por: Chen, Jing, et al.
Publicado: (2019) -
Arsenic trioxide-induced cell apoptosis and cell cycle arrest are potentiated by 1,25-dihydroxyvitamin D3 in human leukemia K562 cells
por: Zhang, Ya-Li, et al.
Publicado: (2021) -
Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells
por: Yi, Juan, et al.
Publicado: (2022) -
Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
por: Han, Weidong, et al.
Publicado: (2011)